Cargando…
CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety
Chimeric antigen receptor-T (CAR-T) cell immunotherapy is a novel method that is genetically engineered to recruit T cells against malignant disease. Administration of CAR-T cells has led to progress in hematological malignancies, and it has been proposed for solid tumors like colorectal cancer (CRC...
Autores principales: | Li, Huali, Yang, Chao, Cheng, Huangrong, Huang, Shuoyang, Zheng, Yongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890323/ https://www.ncbi.nlm.nih.gov/pubmed/33613769 http://dx.doi.org/10.7150/jca.50509 |
Ejemplares similares
-
Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer
por: Huang, Xiaodong, et al.
Publicado: (2020) -
Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma
por: Yang, Chao, et al.
Publicado: (2021) -
A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma
por: Yang, Chao, et al.
Publicado: (2021) -
Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer
por: Yang, Chao, et al.
Publicado: (2021) -
A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study
por: Yang, Chao, et al.
Publicado: (2020)